Kumar R, O'Brien P Q, Fischer A B. "Method for the Synthesis of Ethyl 4-(phenylcarbamoyl)piperazine-1-carboxylate" [P]. US Patent, US 11591621 B2, 2020-05-18.
发明人沈红梅,马晓峰,冯建国. "A Process for Preparing High-Purity Ethyl 4-(phenylcarbamoyl)piperazine-1-carboxylate" [P]. 中国发明专利, 专利号 CN 117729795 A, 授权公告日 2023-05-06.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2014, 892, (1), 2415-2418.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2020, 667, (9), 50-78.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 4-(phenylcarbamoyl)piperazine-1-carboxylate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2016, 1915, 4095-4120.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2024, 1582, 486-491.